Obermatt
See Similar Stocks →

Hyundai Pharmaceutical

KSC:004310 · KR7004310009
PharmaceuticalsSmall

360° View

33
Price/Sales28
Price/Earnings1
Price/Book26
Dividend Yield1
Revenue Growth89
Profit Growth75
Capital Growth88
TSR 52w97
Leverage69
Liquidity37
Refinancing66
Combined60
Analyst Opinions—
Pro Holdings6
Opinion Changes—
Market Pulse4

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees7
Websitehyundaipharm.co.kr
ISINKR7004310009
Last UpdateApr 2, 2026
Index & Theme
OphthalmologyUrologyReproductive HealthDermatologyNutraceuticalCardiovascularPain ManagementInflammationNeurologyWomen's HealthAllergyPharmaceutical

Description

Analysis

Hyundai Pharmaceutical's 360° View rank of 33 places it below its peer average — better than 33% of its true peers.

It's a growth standout (100) and expensive versus peers (6). On safety it is financially sound (61), and the market shows skeptical sentiment (4). Taken together, its Combined rank of 60 reads as above its peer average.

360° rank · history

1007550250
33
2026

All-time high

43

Mar 2026

All-time low

33

Jun 2026

Average rank

38

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
28
—
—
—
Price/Earnings
1
—
—
—
Price/Book
26
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
6
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Hyundai Pharmaceutical with its peers
JW Pharmaceutical
KSC:001060
95
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Chunghwa Chemical Synthesis & Biotech
TAI:1762
13
CountryTaiwan
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Hana Pharm
KSC:293480
88
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Samil Pharmaceutical
KSC:000520
28
CountrySouth Korea
IndustryPharmaceuticals
SizeX-Small
Full Stock Analysis →
Reyon Pharmaceutical
KSC:102460
16
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
PharmGen Science
KSC:004720
74
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →